Corporate Members

HomeATS Community ▶ Corporate Members
Corporate Members

The ATS Corporate Member Program is a vehicle for collaboration between the ATS and its industry partners, in the joined goal of improving patient care and education.

Becoming an ATS Corporate Member is a way for companies to be an active part of the ATS community and to receive recognition from ATS members as supporters of pulmonary, critical care, and sleep medicine specialties. Corporate Members at all levels receive exposure and visibility benefits at the ATS International Conference and in key ATS media throughout the year. Additional benefits of Corporate Membership include complimentary Affiliate Memberships for key staff, the ability to list current clinical trial opportunities, and more.

The ATS 2018 Corporate Member Program runs from March 1, 2018 – Feb. 28, 2019. Visit our Industry Resources webpages for additional information.

For additional information on the program, please contact Vlada O'Hara at vohara@thoracic.org.

 

Untitled Document

Corporate Member Program Header

 

The ATS is pleased to acknowledge its 2020 Corporate Members.

Benefactor

astrazeneca
boehringer-ingelheim
genentech
gsk
jansen
novartis
Sanofi Genzyme Regeneron
theravance
United Theraeutics
vertex

Patron

Amgen
CSL Behring
insmed
mallinckrodt
Merck
mylan
Three Lakes Foundation

Supporter

4D Medical
acceleron
altavant
bayer
bellerophon
FPH
galapagos
jazz pharma
teva
Verona Pharma

Friend

bristol-myers-squibb
Boston Scientific
Pieris
Pulmonx
Sunovion
Veracyte
vitalograph
vivus